What to Do About Late Incomplete Stent Apposition?
2007; Lippincott Williams & Wilkins; Volume: 115; Issue: 18 Linguagem: Inglês
10.1161/circulationaha.107.697136
ISSN1524-4539
Autores Tópico(s)Cerebrovascular and Carotid Artery Diseases
ResumoHomeCirculationVol. 115, No. 18What to Do About Late Incomplete Stent Apposition? Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBWhat to Do About Late Incomplete Stent Apposition? Gary S. Mintz Gary S. MintzGary S. Mintz From the Cardiovascular Research Foundation, New York, NY. Originally published8 May 2007https://doi.org/10.1161/CIRCULATIONAHA.107.697136Circulation. 2007;115:2379–2381Acute and subacute stent thromboses have existed since the first stent implantation procedures. Initially recognized as a complication of brachytherapy, late stent thrombosis has become a public health issue only during the current era of drug-eluting stent (DES) implantation, as evidenced by the March 8, 2007, issue of the New England Journal of Medicine, which includes 5 articles, 2 perspectives, and 1 editorial discussing late DES complications.Article p 2426During every phase of percutaneous coronary intervention, intravascular ultrasound (IVUS) has provided important insights into the mechanisms of success and reasons for failure. In this issue of Circulation, Cook et al1 continue this tradition by reporting the IVUS findings in 13 patients who developed stent thrombosis >1 year after DES implantation. They concluded, "Incomplete stent apposition is highly prevalent in patients with very late stent thrombosis after DES implantation, suggesting a role in the pathogenesis of this adverse event."What Is Incomplete Stent Apposition?Incomplete stent apposition (ISA), synonymous with stent malapposition, is a lack of contact between stent struts and the underlying vessel wall not overlying a side branch. ISA can be quantified by measuring the number of malapposed struts; the arc subtended by the malapposed struts; the distance between the malapposed struts and the vessel wall; and the area, length, and volume of the gap between the stent and vessel wall. ISA must be differentiated from and not confused with stent underexpansion. Stent expansion is the minimum stent area by itself or compared with a predefined reference. Although this distinction may seem obvious, ISA and stent underexpansion are used interchangeably by purported experts. Although the collaborative work of Nakamura and associates2 demonstrated an unexpectedly high percentage of IVUS-detected stent underexpansion and incomplete apposition after angiographically successful bare metal stent (BMS) implantations, no study has linked acute or subacute stent thrombosis to isolated acute ISA. Conversely, stent underexpansion has been a consistent finding in every IVUS report of acute or subacute BMS or DES thrombosis.3–6When and How Often Does ISA Occur, and What Is Its Mechanism?ISA can be acute, occurring at the time of stent implantation, or late, detected at follow-up. Differentiating among the various types and presentations of ISA, specifically identifying the late and acquired variety, requires intravascular imaging (most commonly IVUS) both after stent implantation and at follow-up.Acute ISA is mostly technique dependent and can occur after implantation of any type of stent. Acute ISA can resolve or persist; acute and persistent ISA can increase, remain stable, or decrease in size. It is not clear why some ISA resolves and some persists. However, acute and persistent ISA after DES implantation is associated with less neointimal hyperplasia compared with acute ISA that resolves spontaneously.7,8 Although reendothelialization is below the resolution of IVUS, it is interesting to speculate that acute and persistent ISA also may be associated with reduced reendothelialization compared with acute and resolved ISA.Late ISA, ISA detected at follow-up, can be late and acquired (occurring between implantation and follow-up) or acute and persistent as noted above. The mechanisms of late and acquired ISA are either positive remodeling (an increase in vessel dimensions) without an equal amount of peristent plaque or intimal hyperplasia growth so that the vessel pulls away from the stent (the most common mechanism) or plaque or thrombus dissolution so that a gap forms between the stent and the vessel wall (primarily in patients presenting with acute coronary syndromes).8–13 Although late and acquired ISA can occur after BMS implantation, brachytherapy treatment of BMS restenosis, radioactive stent implantation, and DES implantation, the exact underlying pathological mechanism responsible for positive remodeling remains unknown. Late and acquired ISA is a continuum from 1 malapposed stent strut to aneurysm formation.14 The frequency of late ISA appears to be greater after DES compared with BMS implantation depending on DES type, but it is less clear that the gaps between stent and vessel wall are larger after DES compared with BMS implantation, although aneurysm was rare in the BMS era. Like acute and persistent ISA, late and acquired ISA (whether after BMS or DES implantation) also is associated with less neointimal hyperplasia and presumably reduced reendothelialization.8–10 There are only 2 reports of patients with late ISA who underwent a second follow-up IVUS study; for the most part, ISA in these patients either remained stable or regressed during the second follow-up period.14,15What Is the Diagnostic Accuracy of IVUS in Detecting ISA?There are no studies addressing this issue. It is assumed that IVUS detects significant ISA, missing only minor cases. However, metallic stent struts are strong ultrasound reflectors, and excessive gain settings can exaggerate both reverberations and side lobes to obscure the gap between the struts and the vessel wall. In addition, thrombus formation and blood stasis can fill in this space, and IVUS thrombus detection is notoriously difficult. Documentation of ISA is enhanced by flushing saline or contrast from the guiding catheter to wash out static blood and/or to confirm the presence or absence of flow.How Predictive Is ISA for Late Stent Thrombosis?Although the IVUS literature has speculated that late and acquired ISA could lead to stent thrombosis, the report by Cook et al1 is the first to document this association convincingly. Let us examine their data in detail.None of the patients with late stent thrombosis had baseline IVUS; therefore, it was not possible to differentiate acute and persistent ISA from late and acquired ISA. However, this may not be as important as the size of the stent–vessel wall gaps or the underlying pathology.Late ISA was present in 10 of 13 late stent thrombosis patients and measured 8.3±7.5 mm2 in maximum cross-sectional area (range, 2 to 24 mm2), with 9 of 10 late stent thrombosis patients having a gap of ≥4 mm2. To put this in perspective, the average late ISA area in the stent thrombosis patients in the study by Cook et al was great than the average minimum stent area in these patients. Furthermore, this average late ISA area was twice the size of the average late ISA of the 21 control patients (4.0 mm2), the average late ISA area of the 7 slow-release and 10 moderate-release patients in the TAXUS-II trial (5.1 mm2 and 3.4 mm2, respectively), and the average late ISA area of 85 DES-treated patients reported by Hong et al8 (3.0 mm2)—none of whom had late sequelae. These were not subtle findings—cases of malapposition likely to be missed by IVUS and requiring more advanced intracoronary imaging techniques; they represented the extreme end of the spectrum, with 3 of 10 having frank aneurysms (lumen [stent+ISA] area >50% larger than the proximal reference), similar to the 2 patients reported by Feres et al16 who developed late stent thrombosis after follow-up IVUS detected marked late and acquired ISA.What of the other 3 patients? One had a minimum stent area of 5.0 mm2, and the other 2 had no IVUS-detectable explanation for late thrombosis. It is possible that ISA was missed because thrombus formation obscured the stent–vessel wall gap.It has long been speculated that underexpansion and malapposition have a synergistic effect on stent thrombosis. Thus, the authors calculated a stent expansion index, dividing the minimum stent area by the reference lumen area, to show that stent expansion was less in late stent thrombosis patients compared with control subjects. Does this make sense? No, not in the conventional sense in which stents were underexpanded at implantation and underexpansion was detected only at follow-up. In fact, minimum stent area was similar between stent thrombosis and control patients. Instead, positive remodeling (increase in vessel dimensions), which was responsible for late and acquired ISA, probably affected the reference segments, causing an increase in vessel and lumen dimensions and artificially reducing the expansion index. This highlights the diffuse nature of this positive remodeling in these patients. It is not known whether a mere mismatch between an adequate absolute minimum stent area and a larger reference lumen area (rather than true underexpansion) contributes to stent thrombosis. However, the findings of Cook et al suggest a lessening of the impact of mechanical stent implantation problems on late stent thrombosis compared with acute/subacute stent thrombosis.1 Only 3 of 13 of late stent thrombosis patients had "real" stent underexpansion, a minimum stent area <5.0 to 5.5 mm2 (a common criterion for DES underexpansion6,17,18), fewer than have been reported with IVUS studies of acute/subacute thrombosis.Does ISA in and of Itself Cause Late Stent Thrombosis?In a recent article in this journal, Luscher and coworkers19 state, "We have shown that in humans delayed healing is common with current DES and that in those that thrombose, other factors, such as hypersensitivity reaction, bifurcating and ostial stenting, penetration of a necrotic core, stent malapposition, and restenosis, may also be important predictors of thrombosis." I would turn this around to state that late ISA (whether acute and persistent or late and acquired) is common, occurring in 10% to 20% of DES1,8,12,20; in patients who thrombose, other factors such as delayed healing, inflammation, and hypersensitivity must also play a role.Is This an Argument for Routine Use of IVUS?On one hand, it is possible to argue that routine IVUS during DES implantation will minimize stent underexpansion, uncovered edge stenoses, and acute ISA and that this will reduce restenosis, acute/subacute thrombosis, and perhaps the minority of cases of late stent thrombosis that can be attributed to implantation issues. It is also easy to argue that patients with clinical events should undergo IVUS in an attempt to determine the cause of DES failure, as was done in the study by Cook et al1 However, it is harder to argue that routine baseline or follow-up IVUS will eliminate late thrombosis. First, late ISA is common, and the majority of IVUS-detected late ISA is not associated with clinical sequelae. Second, only rare cases of late thrombosis have had IVUS at implantation and/or prior follow-up. Third, the time for follow-up IVUS would be totally empirical. Fourth, the incidence of late stent thrombosis is low. Finally, what should the clinician do with this information? Although it is possible to dilate the stent further to decrease the magnitude of ISA, it may be impossible to abolish the large stent–vessel wall gaps reported by Cook et al1 and Feres et al.16 Furthermore, in some patients, late ISA may be progressive, or reestablishing stent–vessel wall contact may reinvigorate the process that produced positive remodeling and late ISA. Finally, it is not clear that merely reducing or even abolishing these gaps will eliminate late thrombosis.What Next?IVUS data are available in only a minority of patients in multicenter trials, in part because most of these trials included only a small IVUS substudy but also because of poor investigator compliance within the substudy. With the notable exception of TAXUS-II (in which IVUS was the primary end point and therefore was performed in 85%13), follow-up IVUS adequate to detect late ISA was available in only ≈40% of patients in RAVEL,20 15% of patients in SIRIUS,12 and 20% of patients in an integrated analysis of TAXUS-IV, V, and VI. Paired (postintervention and follow-up) IVUS, necessary to detect late and acquired ISA, was done in even fewer patients. Among these multicenter studies, there were <100 patients with late ISA, and only half of them had late and acquired ISA. The single-center study by Hong et al8 alone contained 133 patients with late ISA, 82 of whom had late and acquired ISA. Importantly, none of these studies reported late stent thrombosis in any late ISA patient either at the time of detection or during subsequent clinical follow-up, although the size of the ISA was similar to that in the control group in the study by Cook et al.The report by Cook et al1 raises as many questions as it answers. It is possible to conceive of a study that would answer some of these questions: baseline (blinded) IVUS, routine IVUS follow-up with randomization of late ISA patients to additional stent expansion versus no intervention, and subsequent clinical follow-up with IVUS imaging of patients presenting with late events. Given the relative infrequency of each event, the difficulty in collecting comprehensive data (particularly the required IVUS data), the "modest" reported size of late ISA in large prospective studies, and the protracted follow-up that would be necessary, the number of patients and the time course would be daunting. For now, we must rely on important observations such as the study performed by Cook and colleagues that provide insights into this clinical problem, and the question of whether identifying and treating late ISA will reduce late stent thrombosis remains unanswered.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.DisclosuresDr Mintz is a member of the speakers' bureau for Boston Scientific Corp and is a consultant for and shareholder of Volcano Corp.FootnotesCorrespondence to Gary S. Mintz, MD, 611 Pennsylvania Ave, SE No. 386, Washington, DC 20003. E-mail [email protected] References 1 Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess OM, Meier B, Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007; 115: 2426–2434.LinkGoogle Scholar2 Nakamura S, Colombo A, Gaglione A, Almagor Y, Goldberg SL, Maiello L, Finci L, Tobis JM. Intracoronary ultrasound observations during stent implantation. Circulation. 1994; 89: 2026–2034.CrossrefMedlineGoogle Scholar3 Uren NG, Schwarzacher SP, Metz JA, Lee DP, Honda Y, Yeung AC, Fitzgerald PJ, Yock PG, for the POST Registry Investigators. Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry. Eur Heart J. 2002; 23: 124–132.CrossrefMedlineGoogle Scholar4 Alfonso F, Suarez A, Angiolillo DJ, Sabate M, Escaned J, Moreno R, Hernandez R, Banuelos C, Macaya C. Findings of intravascular ultrasound during acute stent thrombosis. Heart. 2004; 90: 1455–1459.CrossrefMedlineGoogle Scholar5 Cheneau E, Leborgne L, Mintz GS, Kotani J, Pichard AD, Satler LF, Canos D, Castagna M, Weissman NJ, Waksman R. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation. 2003; 108: 43–47.LinkGoogle Scholar6 Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005; 45: 995–998.CrossrefMedlineGoogle Scholar7 Kimura M, Mintz GS, Carlier S, Takebayashi H, Fujii K, Sano K, Yasuda T, Costa RA, Costa JR Jr, Quen J, Tanaka K, Lui J, Weisz G, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. Am J Cardiol. 2006; 98: 436–442.CrossrefMedlineGoogle Scholar8 Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006; 113: 414–419.LinkGoogle Scholar9 Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ. Incidence, mechanism, predictors, and long-term prognosis of late malapposition after bare metal stent implantation. Circulation. 2004; 109: 881–886.LinkGoogle Scholar10 Shah VM, Mintz GS, Apple S, Weissman NJ. Background incidence of late malapposition after bare-metal stent implantation. Circulation. 2002; 106: 1753–1755.LinkGoogle Scholar11 Mintz GS, Shah VM, Weissman NJ. Regional remodeling as the cause of late stent malapposition. Circulation. 2003; 107: 2660–2663.LinkGoogle Scholar12 Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, Leon MB, Moses JW, Bonneau HN, Fitzgerald PJ. Late incomplete stent apposition after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2005; 46: 1002–1005.CrossrefMedlineGoogle Scholar13 Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, Bonnier J, Lablanche JM, Siminiak T, Nordrehaug J, Figulla H, Drzewiecki J, Banning A, Hauptmann K, Dudek D, Bruining N, Hamers R, Hoye A, Ligthart JM, Disco C, Koglin J, Russell ME, Colombo A, for the TAXUS II Study Group. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS-II Trial. Circulation. 2005; 11: 900–905.Google Scholar14 Degertekin M, Serruys PW, Tanabe K, Lee CH, Sousa JE, Colombo A, Morice MC, Ligthart JM, de Feyter PJ. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation. 2003; 108: 2747–2750.LinkGoogle Scholar15 Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K, Schiele F, Russell ME, Koglin J, Serruys PW, for the TAXUS II Study Group. Persistent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS-II Study. Circulation. 2005; 112: 3876–3883.LinkGoogle Scholar16 Feres F, Costa JR Jr, Abizaid A. Very late thrombosis after drug-eluting stents. Catheter Cardiovasc Interv. 2006; 68: 83–88.CrossrefMedlineGoogle Scholar17 Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, Leon MB, Moses JW, Yock PG, Honda Y, Kuntz RE, Fitzgerald PJ, for the SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol. 2004; 43: 1959–1963.CrossrefMedlineGoogle Scholar18 Hong MK, Mintz GS, Lee CW, Park DW, Choi BR, Park KH, Kim YH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J. 2006; 27: 1305–1310.CrossrefMedlineGoogle Scholar19 Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007; 115: 1051–1058.LinkGoogle Scholar20 Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, Guagliumi G, Wijns W, Lindeboom WK, Ligthart J, de Feyter PJ, Morice MC, for the RAVEL Study Group. Intravascular ultrasound findings in the multicenter, randomized RAVEL trial. Circulation. 2002; 106: 789–803.Google Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Shiozaki S, Otani T, Fujimura S, Takao H and Wada S (2020) Computational modeling of braided‐stent deployment for interpreting the mechanism of stent flattening, International Journal for Numerical Methods in Biomedical Engineering, 10.1002/cnm.3335, 37:12, Online publication date: 1-Dec-2021. Kreuser L, Laugwitz K, Tiemann K, Lewalter T and Jilek C (2020) Preparation of PCI Balloons: What Is the Best Method to Avoid Air in the Balloon? A Comparison of Different Methods of Connecting PCI Balloons and the Inflation Syringe while Removing Air from the Balloon, Journal of Clinical Medicine, 10.3390/jcm9010172, 9:1, (172) Uchimura Y, Itoh T, Oda H, Taguchi Y, Sasaki W, Kaneko K, Sakamoto T, Goto I, Sakuma M, Ishida M, Kikuchi T, Terashita D, Otake H, Morino Y and Shinke T (2019) Cut-off value of mal-apposition volume and depth for resolution at early phase of acute incomplete stent apposition after CoCr-EES implantation, The International Journal of Cardiovascular Imaging, 10.1007/s10554-019-01657-y, 35:11, (1979-1987), Online publication date: 1-Nov-2019. Piraino D, Cimino G, Buccheri D and Andolina G (2018) In-Stent Restenosis: Definition, Entity of the Problem, Etiopathogenesis and Treatment Options Textbook of Catheter-Based Cardiovascular Interventions, 10.1007/978-3-319-55994-0_58, (975-994), . Sato T, Tölg R, El-Mawardy M, Sulimov D, Richardt G and Abdel-Wahab M (2017) The fate of incomplete scaffold apposition of everolimus-eluting bioresorble scaffolds: A serial optical coherence tomography analysis, Journal of Cardiology, 10.1016/j.jjcc.2017.03.007, 70:5, (454-460), Online publication date: 1-Nov-2017. Alraies M, Darmoch F, Tummala R and Waksman R (2017) Diagnosis and management challenges of in-stent restenosis in coronary arteries, World Journal of Cardiology, 10.4330/wjc.v9.i8.640, 9:8, (640), . Kovárník T, Kopřiva K and Jeřábek Š (2016) Suboptimal stent apposition - treat or leave it?, Intervenční a akutní kardiologie, 10.36290/kar.2016.027, 15:3, (135-139), Online publication date: 1-Oct-2016. Roopmani P, Sethuraman S, Satheesh S and Maheswari Krishnan U (2016) The metamorphosis of vascular stents: passive structures to smart devices, RSC Advances, 10.1039/C5RA19109B, 6:4, (2835-2853) Nakamura A, Noda K, Nakajima S, Endo H, Takahashi T and Nozaki E (2014) Contrast stainings outside the stents of the superficial femoral artery after polymer-free drug-eluting peripheral stents implantation, Cardiovascular Intervention and Therapeutics, 10.1007/s12928-014-0290-4, 30:3, (293-298), Online publication date: 1-Jul-2015. La Manna A, Mangiameli A, Capodanno D, Longo G, Sgroi C and Tamburino C (2015) Managing Bioabsorbable Vascular Scaffold Failure: Combined Scaffold Restenosis and Late-Acquired Coronary Aneurysm Treated With Self-Expandable Stent, Canadian Journal of Cardiology, 10.1016/j.cjca.2014.12.021, 31:5, (691.e1-691.e3), Online publication date: 1-May-2015. Radu M, Kelbæk H, Jørgensen E, Helqvist S, Løjmand B, Engstrøm T and Saunamäki K (2014) Intracoronary Optical Coherence Tomography: Insights from Clinical Research—What Do We Need to Learn?, Current Cardiovascular Imaging Reports, 10.1007/s12410-014-9286-9, 7:9, Online publication date: 1-Sep-2014. Attizzani G, Capodanno D, Ohno Y and Tamburino C (2014) Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition, Journal of the American College of Cardiology, 10.1016/j.jacc.2014.01.019, 63:14, (1355-1367), Online publication date: 1-Apr-2014. Im E, Kim B, Ko Y, Shin D, Kim J, Choi D, Jang Y and Hong M (2014) Incidences, Predictors, and Clinical Outcomes of Acute and Late Stent Malapposition Detected by Optical Coherence Tomography After Drug-Eluting Stent Implantation, Circulation: Cardiovascular Interventions, 7:1, (88-96), Online publication date: 1-Feb-2014. Sidharta S, Worthley M and Worthley S (2014) Use of Intravascular Ultrasound in Interventional Cardiology Imaging Coronary Atherosclerosis, 10.1007/978-1-4939-0572-0_4, (51-66), . Guo N and Mintz G (2014) Quantitative, Qualitative, and Diagnostic Intravascular Ultrasound Textbook of Cardiovascular Intervention, 10.1007/978-1-4471-4528-8_3, (23-39), . Madan V, Coppola J and Sedlis S (2013) Avoiding stent thrombosis: advances in technique, antiplatelet pharmacotherapy and stent design, Interventional Cardiology, 10.2217/ica.13.10, 5:2, (179-201), Online publication date: 1-Apr-2013. Li S, Gai L, Yang T, Zhang L, Xu X, Bai Q, Xu H and Wang Y (2012) Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography, Catheterization and Cardiovascular Interventions, 10.1002/ccd.24497, 81:5, (768-775), Online publication date: 1-Apr-2013. Li S, Wang Y, Gai L, Yang T, Liu H, Wang Z, Bai Q, Xu X and Chen Y (2013) Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography, International Journal of Cardiology, 10.1016/j.ijcard.2011.05.076, 162:3, (166-171), Online publication date: 1-Jan-2013. Lanzer P (2013) Intracoronary Stenting Strategies Catheter-Based Cardiovascular Interventions, 10.1007/978-3-642-27676-7_29, (497-529), . Guo N and Mintz G (2012) Drug-eluting stent malapposition and its relationship to drug-eluting stent thrombosis, Interventional Cardiology, 10.2217/ica.12.53, 4:5, (521-525), Online publication date: 1-Oct-2012. Cassese S, Tada T and Kastrati A (2012) Lost contact with vessel wall, signed contract with stent thrombosis?, European Heart Journal, 10.1093/eurheartj/ehs039, 33:11, (1305-1308), Online publication date: 1-Jun-2012. Cook S, Eshtehardi P, Kalesan B, Raber L, Wenaweser P, Togni M, Moschovitis A, Vogel R, Seiler C, Eberli F, Luscher T, Meier B, Juni P and Windecker S (2012) Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation, European Heart Journal, 10.1093/eurheartj/ehr484, 33:11, (1334-1343), Online publication date: 1-Jun-2012. Davlouros P, Mavronasiou E, Xanthopoulou I, Karantalis V, Tsigkas G, Hahalis G and Alexopoulos D (2012) An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9, International Journal of Cardiology, 10.1016/j.ijcard.2010.12.072, 157:3, (341-346), Online publication date: 1-Jun-2012. Davlouros P, Nikokiris G, Karantalis V, Mavronasiou E, Xanthopoulou I, Damelou A, Tsigkas G and Alexopoulos D (2011) Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: An optical coherence tomography study, International Journal of Cardiology, 10.1016/j.ijcard.2010.05.004, 151:2, (155-159), Online publication date: 1-Sep-2011. Takarada S, Kern M and Akasaka T (2011) Intracoronary Optical Frequency Domain Imaging for Identifying Stent-Related Complications, Current Cardiovascular Imaging Reports, 10.1007/s12410-011-9088-2, 4:4, (292-297), Online publication date: 1-Aug-2011. Bourantas C, Naka K, Garg S, Thackray S, Papadopoulos D, Alamgir F, Hoye A and Michalis L (2010) Clinical Indications for Intravascular Ultrasound Imaging, Echocardiography, 10.1111/j.1540-8175.2010.01259.x, 27:10, (1282-1290), Online publication date: 1-Nov-2010. Singh H, Kirtane A and Moses J (2010) AngioSculpt ® scoring balloon catheter: an atherotomy device for coronary and peripheral interventions , Interventional Cardiology, 10.2217/ica.10.51, 2:4, (469-478), Online publication date: 1-Aug-2010. Garg S and Serruys P (2010) Coronary Stents, Journal of the American College of Cardiology, 10.1016/j.jacc.2010.06.007, 56:10, (S1-S42), Online publication date: 1-Aug-2010. Schweizer S, Schuster T, Junginger M, Siekmeyer G and Taubert A (2010) Surface Modification of Nickel/Titanium Alloy and Titanium Surfaces via a Polyelectrolyte Multilayer/Calcium Phosphate Hybrid Coating, Macromolecular Materials and Engineering, 10.1002/mame.200900347, 295:6, (535-543) Ozaki Y, Okumura M, Ismail T, Naruse H, Hattori K, Kan S, Ishikawa M, Kawai T, Takagi Y, Ishii J, Prati F and Serruys P (2010) The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study, European Heart Journal, 10.1093/eurheartj/ehq066, 31:12, (1470-1476), Online publication date: 2-Jun-2010. Hassan A, Bergheanu S, Stijnen T, van der Hoeven B, Snoep J, Plevier J, Schalij M and Wouter Jukema J (2009) Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis, European Heart Journal, 10.1093/eurheartj/ehn553, 31:10, (1172-1180), Online publication date: 2-May-2010. Steinberg D, Mintz G, Mandinov L, Yu A, Ellis S, Grube E, Dawkins K, Ormiston J, Turco M, Stone G and Weissman N (2010) Long-Term Impact of Routinely Detected Early and Late Incomplete Stent Apposition, JACC: Cardiovascular Interventions, 10.1016/j.jcin.2010.03.007, 3:5, (486-494), Online publication date: 1-May-2010. Lindsey J and Marso S (2010) Incomplete Stent Apposition, JACC: Cardiovascular Interventions, 10.1016/j.jcin.2010.03.005, 3:5, (495-497), Online publication date: 1-May-2010. Lee C, Kang S, Park D, Lee S, Kim Y, Kim J, Park S, Mintz G and Park S (2010) Intravascular Ultrasound Findings in Patients With Very Late Stent Thrombosis After Either Drug-Eluting or Bare-Metal Stent Implantation, Journal of the American College of Cardiology, 10.1016/j.jacc.2009.10.077, 55:18, (1936-1942), Online publication date: 1-May-2010. Garg S and Serruys P (2014) Benefits of and safety concerns associated with drug-eluting coronary stents, Expert Review of Cardiovascular Therapy, 10.1586/erc.09.138, 8:3, (449-470), Online publication date: 1-Mar-2010. Choi H, Hur S, Nam C, Cho Y, Kim H, Park N, Kim Y and Kim K (2010) Extensive Late-Acquired Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation, Korean Circulation Journal, 10.4070/kcj.2010.40.1.50, 40:1, (50), . Park S, Kim Y and Kang S (2009) Response to Letter Regarding Article, "Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis", Circulation: Cardiovascular Interventions, 2:5, (e4-e4), Online publication date: 1-Oct-2009. DE PRADO A, MARTINEZ C, RAMON C, ORDEN J, ALTONAGA J, IGLESIAS M, PURRIÑOS M, ORDEN M, MARIN J and FERNANDEZ-VAZQUEZ F (2009) Endothelialization of Nonapposed Stent Struts Located over the Origin of a Side Branch: Results with Different Carbofilm-Coated Stents, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2009.00458.x, 22:3, (222-227), Online publication date: 1-Jun-2009. Jensen L, Maeng M, Mintz G, Christiansen E, Hansen K, Galloe A, Kelbaek H, Lassen J, Thuesen L and Thayssen P (2009) Serial Intravascular Ultrasound Analysis of Peri-Stent Remodeling and Proximal and Distal Edge Effects After Sirolimus-Eluting or Paclitaxel-Eluting Stent Implantation in Patients With Diabetes Mellitus, The American Journal of Cardiology, 10.1016/j.amjcard.2008.12.035, 103:8, (1083-1088), Online publication date: 1-Apr-2009. Colombo A and Gerber R (2008) Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?, Circulation: Cardiovascular Interventions, 1:3, (226-232), Online publication date: 1-Dec-2008. Brown M, Tran T and Krone R (2008) Drug-eluting stents: Are they still the answer?, Current Cardiovascular Risk Reports, 10.1007/s12170-008-0061-9, 2:5, (334-341), Online publication date: 1-Sep-2008. Slottow T and Waksman R (2007) Drug-Eluting Stent Safety, The American Journal of Cardiology, 10.1016/j.amjcard.2007.08.017, 100:8, (S10-S17), Online publication date: 1-Oct-2007. May 8, 2007Vol 115, Issue 18 Advertisement Article InformationMetrics https://doi.org/10.1161/CIRCULATIONAHA.107.697136PMID: 17485592 Originally publishedMay 8, 2007 KeywordsultrasonicsEditorialsremodelingthrombosisstentsPDF download Advertisement SubjectsImagingStent
Referência(s)